|
Volumn 111, Issue 5, 2001, Pages 407-408
|
Hemoglobinopathies: An opportunity to study cardiac disease
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DEFEROXAMINE;
FERRITIN;
BETA THALASSEMIA;
CELL PROLIFERATION;
CELL TRANSFORMATION;
CHELATION THERAPY;
CLINICAL FEATURE;
DISEASE COURSE;
EDITORIAL;
FIBROMUSCULAR DYSPLASIA;
FOLLOW UP;
HEALTH CARE;
HEART DISEASE;
HEART MUSCLE BIOPSY;
HEART MUSCLE INJURY;
HEART MUSCLE PERFUSION;
HEART VENTRICLE CONTRACTILITY;
HEMOGLOBINOPATHY;
HUMAN;
IRON CHELATION;
OCCUPATIONAL HEALTH;
ORGAN TRANSPLANTATION;
PRIORITY JOURNAL;
RECURRENT DISEASE;
SICKLE CELL ANEMIA;
TREATMENT OUTCOME;
ANEMIA, SICKLE CELL;
BETA-THALASSEMIA;
HEART DISEASES;
HUMANS;
IRON CHELATING AGENTS;
RISK FACTORS;
|
EID: 0035478793
PISSN: 00029343
EISSN: None
Source Type: Journal
DOI: 10.1016/S0002-9343(01)00943-3 Document Type: Editorial |
Times cited : (2)
|
References (17)
|